ISS-peanut allergen conjugate (Dynavax/Mount Sinai)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameISS-peanut allergen conjugate (Dynavax/Mount Sinai)
Drug Alias NameN/A
ClassificationBiologics > Protein drugsVaccines > Application > Therapeutic vaccine
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsHypersensitivity, ImmediateHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDynavax Technologies Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDynavax Technologies CorpIcahn School Of Medicine At Mount Sinai
Active IndicationsN/A
Inactive IndicationsHypersensitivity, ImmediateHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A